Follow

Submissions from 2022

 

Shaping the Landscape of Brain Metastases Research, Minesh Mehta

 

Shaping the Landscape of Brain Metastases Research: History of Brain Metastases Trials, What are the Cooperative Groups Doing, What is the Next Generation of Brain Metastases Clinical Trials, Minesh Mehta

 

Shaping the Landscape of Brain Metastases Research: What Matters Most to Patients, Minesh Mehta

 

Multidisciplinary Management of Hepatocellular Carcinoma: Understanding the evolving treatment landscape, Domenech Asbun

PDF

Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy, Cristina Lopez-Penalver

PDF

Race, Rituximab, and Relapse in TTP, Camila Masias Castanon

 

Providing Patients’ Tomorrow’s Care Today: Rapidly Bringing Discovery to the Bedside, Minesh Mehta

PDF

Causes of Death Among Patients With Initially Inoperable Pancreas Cancer After Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy, Michael Chuong, Roberto Herrera, Antonio Ucar, Santiago Aparo, Fernando De Zarraga, Domenech Asbun, Javier Jimenez, Horacio Asbun, Govindarajan Narayanan, Sarah Joseph, Rupesh Kotecha, Matthew Hall, Kathryn Mittauer, Diane Alvarez, James McCulloch, Tino Romaguera, Alonso Gutierrez, and Adeel Kaiser

PDF

Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy, Yazmin Odia, Doured Daghistani, Zuanel Diaz, and Matthew Hall

PDF

SerpinB3 drives cancer stem cell survival in glioblastoma, Manmeet Ahluwalia

 

Clinical Trials Lessons Learned, Minesh Mehta

 

From Bench to Bedside to Beam: Radiotherapy Advances for Brain Tumors., Minesh Mehta

 

Colecistectomia Segura, Domenech Asbun

PDF

Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel, Reshma Mahtani

PDF

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial, Michael Chuong

 

Maximizing Angioplasty Results in Peripheral Interventions, Austin Pourmoussa, Constantino Pena, and Barry Katzen

 

Maximizing Angioplasty Results in Peripheral Interventions, Austin Pourmoussa, Constantino Pena, and Barry Katzen

 

Photon versus proton whole ventricular radiotherapy for non-germinomatous germ cell tumors: A report from the Children's Oncology Group, Matthew Hall

 

The Graded Prognostic Assessment (GPA) for Lung Cancer Patients with Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA including the Effect of Programmed Death Ligand-1 (PD-L1) and Other Prognostic Factors, Tugce Kutuk, Rupesh Kotecha, Manmeet Ahluwalia, and Minesh Mehta

 

Multimodality Approaches to Primary and Secondary Brain Tumors, Minesh Mehta

 

Radiation therapy alone versus radiation therapy plus radiofrequency ablation/vertebral augmentation for spine metastasis: trial in progress, Rupesh Kotecha, Brian Schiro, Justin Sporrer, Muni Rubens, Haley Appel, Martin Tom, and Minesh Mehta

 

Pearls and Pitfalls in Conducting Neuro-Oncology Trials: Reflections of Experienced Clinical Trialists, Minesh Mehta

 

Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data, Tugce Kutuk, Haley Appel, Federico Albrecht, Paul Kaywin, Suyen Ramos, Minesh Mehta, and Rupesh Kotecha

 

Keynote B36: Open-label study of first-line tumor treating fields (150kHz) plus pembrolizumab for non-small cell lung cancer, Rupesh Kotecha

 

Multi-Institutional Patterns of Use and Compliance with Tumor Treating Fields for Patients with Unresectable Malignant Pleural Mesothelioma, Tugce Kutuk and Rupesh Kotecha